← Evidence map

ReviewPharmacoEconomics2006

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.

Sophie Beale et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2006

2007

2008

2009

2010

this papercites it

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK. | Socratic